Glycobond Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
3

- Latest Deal Type
-
Liquidation
Glycobond General Information
Description
Developer of carbohydrate-binding peptides designed to diagnose and monitor liver diseases and cancer. The company's peptides are developed using recombinant technology with defined specificities to detect aberrant and cancer-specific glycosylation, an acute-phase plasma protein produced mainly in the liver, enabling physicians to diagnose primary liver diseases and cancer.
Contact Information
Website
www.glycobond.comCorporate Office
- Teknikringen 1F
- 583 30 Linkoping
- Sweden
Corporate Office
- Teknikringen 1F
- 583 30 Linkoping
- Sweden
Glycobond Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Bankruptcy: Liquidation | 02-Sep-2024 | Completed | Bankruptcy: Liquidation | |||
6. Later Stage VC | 31-Dec-2020 | Completed | Generating Revenue | |||
5. Grant | 15-Dec-2017 | Completed | Generating Revenue | |||
4. Later Stage VC | 11-Apr-2017 | Completed | Generating Revenue | |||
3. Later Stage VC | 08-Nov-2016 | Completed | Generating Revenue | |||
2. Early Stage VC | 08-Apr-2015 | Completed | Generating Revenue | |||
1. Accelerator/Incubator | 01-Jan-2015 | Completed | Generating Revenue |
Glycobond Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary |
Glycobond Patents
Glycobond Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11467162-B2 | Diagnostic test for hepatocellular carcinoma | Active | 09-May-2016 | ||
US-20200319189-A1 | Diagnostic test for hepatocellular carcinoma | Active | 09-May-2016 | ||
JP-6189499-B1 | Novel binding assay | Active | 09-May-2016 | ||
EP-3455634-A2 | Novel binding assay | Inactive | 09-May-2016 | ||
JP-2017203762-A | Novel binding assay | Active | 09-May-2016 | G01N33/57438 |
Glycobond Signals
Glycobond FAQs
-
When was Glycobond founded?
Glycobond was founded in 2011.
-
Where is Glycobond headquartered?
Glycobond is headquartered in Linkoping, Sweden.
-
What is the size of Glycobond?
Glycobond has 3 total employees.
-
What industry is Glycobond in?
Glycobond’s primary industry is Discovery Tools (Healthcare).
-
Is Glycobond a private or public company?
Glycobond is a Private company.
-
What is Glycobond’s current revenue?
The current revenue for Glycobond is
. -
How much funding has Glycobond raised over time?
Glycobond has raised $167K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »